This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Berd, D., Maguire, H.C., Jr., and Mastrangelo, M.J., 1986, Induction of cell-mediated immunity to autologous melanoma cells and regression of metastases after treatment with a melanoma cell vaccinia preceded by cylophosphamide, Cancer Res. 46:2572–2577.
Cole, D.J., Wilson, M.C., Baron, P.L., O’Brien, P., Reed, C., Tsang, K.Y., and Schlom, J., 1996, Phase I study of recombinant CEA vaccinia virus vaccine with post vaccination CEA peptide challenge, Hum. Gen. Ther. 7:1381–1394.
Cooney, E.L., Collier, A.C., Greenberg, P.D., Coombs, R.W., Zarling, J., Arditti, D.E., Hoffman, M.C., Hu, S.L., and Corey, L., 1991, Safety of and immunologic response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein, Lancet 337:567–572.
Dranoff, G., Jaffee. E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V, Hamada, H., Pardoll, D.M., and Mulligan, H.C., 1993, Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony stimulating factor stimulated potent, specific and long-lasting anti-tumor immunity, Proc. Natl. Acad. Sci. U.S.A., 90:3539–3543.
Everall, J.D., O’Doherty, C.J., Ward, J., and Dowd, P.M., 1975, Treatment of primary melanoma by intralesional vaccinia before excision, Lancet 2:583–586.
Golumbek, P.T., Lanzenby, A.J., Levitsky, H.I., Jaffee, L.M., Karasuyama, H., Baker, M., and Pardoll, D.M., 1991, Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4, Science 254:713–716.
Gomella, L.G., Mastrangelo, M.J., Eisenlohr, L.C., McCue, P.A., Monken, C.E., Kovatich, A.J., Mulholland, S.G., Maguire, H.C. Jr., and Lattime, E.C., 1997, Phase I study of intravesical vaccinia virus as a vector for gene therapy of bladder cancer, Proc. Am. Assoc. Cancer Res. 38:9.
Harris, D.T., Matyas G., Mastrangelo, M.J., Muderhwa, J.M., Alving, C., Maida, A., and Spitler, L.E., 1998, OncoVax-Ptm Vaccine: Pilot studies in prostate cancer patients, Proc. Am. Soc. Clin. Oncol. 17:428a.
Jones, T., Stern, A., and Lin. R., 1994, Potential role of granulocyte-macrophage colony-stimulating factor as vaccine adjuvant, Eur. J. Clin. Microbiol. Infect. Dis. 13 (Suppl. 2):S47–S53.
Lee, S.S., Eisenlohr, L.C., McCue, P.A., Mastrangelo, M.J., and Lattime, E.C., 1994, Intravesical gene therapy: In-vivo gene transfer using vaccinia vectors, Cancer Res. 54:3325–3328.
Leukine, in: Physician’s Desk Reference, 49th Edition, 1995, pp 1161–1164, Medical Economics Data Production Co., Montvale, N.J., U.S.A.
Maguire, H.C., Jr., 1995, Murine recombinant interleukin-12 increases the acquisition of allergic contact dermatitis in the mouse, Int. Arch. Allergy Immunol. 106:166–168.
Mastrangelo, M.J., Maguire, H.C., Jr., McCue, P., Lee, S.S., Alexander, A.A., Nazarian, L.N., Eisenlohr, L.C., Nathan, F., Berd, D., and Laltime, B.C., 1995, A pilot study demonstrating the feasibility of using intra-tumoral vaccinia injections as a vector for gene transfer, Vaccine Res. 4:55–69.
Mastrangelo, M.J., Berd, D., Nathan, F.E., and Lattime, E.C., 1996, Gene therapy for human cancer: An essay for clinicians, Semin. Oncol. 23:4–21.
Mastrangelo, M.J., Maguire, H.C., Jr., Eisenlohr, L.C., Laughlin, C.E., Monken, C.E., McCue, PA., Kovatich, A.J., and Lattime E.C., 1999, Intratumoral recombinant GM-CSF encoding virus as gene therapy in patients with cutaneous melanoma, Cancer Gen. Ther. (in press).
Mehregan, D.R., Fransway, A.F., Edmonson, J.H., and Leiferman, K.M., 1992, Cutaneous reactions to granulocyte-macrophage colony-stimulating factor, Arch. Dermatol. 128:1055–1059.
Moss, B., 1991, Vaccinia virus: A tool for research and development, Science 252:1660–1667.
Russo, D.M., Sundy, J.S., Young, J.F., Maguire, H.C., Jr., and Weidanz, W.P., 1989, Cell mediated immune responses to vaccine peptides derived from the circumsporozoite protein of Plasmodium falciparum, J. Immunol. 143:655–659.
Shimizu, Y, Hasumi, K.., Masubuchi, K.., and Okudaira, Y., 1988, Immunotherapy of tumor-bearing mice utilizing virus help, Cancer Immunol. Immunother. 27:223–227.
Vaccinia (Smallpox) vaccine. Recommendations of the Immunization Practices Committee, 1985, MMWR 34:341–342.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Mastrangelo, M.J., Maguire, H.C., Lattime, E.C. (2002). Intralesional Vaccinia/GM-CSF Recombinant Virus in the Treatment of Metastatic Melanoma. In: Habib, N.A. (eds) Cancer Gene Therapy. Advances in Experimental Medicine and Biology, vol 465. Springer, New York, NY. https://doi.org/10.1007/0-306-46817-4_34
Download citation
DOI: https://doi.org/10.1007/0-306-46817-4_34
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-306-46191-0
Online ISBN: 978-0-306-46817-9
eBook Packages: Springer Book Archive